• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ARROW INTERNATIONAL INC. REDIGUARD IAB: 8FR 40CC; SYSTEM, BALLOON, INTRA-AORTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ARROW INTERNATIONAL INC. REDIGUARD IAB: 8FR 40CC; SYSTEM, BALLOON, INTRA-AORTIC Back to Search Results
Model Number IPN000263
Device Problem Material Puncture/Hole (1504)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 11/09/2020
Event Type  malfunction  
Manufacturer Narrative
Qn#: (b)(4).
 
Event Description
It was reported that the intra-aortic balloon (iab) ruptured during use on a patient.As a result, the iab was removed and a second iab was inserted at the same insertion site.There was no report of patient complications, serious injury or death.
 
Event Description
It was reported that the intra-aortic balloon (iab) ruptured during use on a patient.As a result, the iab was removed and a second iab was inserted at the same insertion site.There was no report of patient complications, serious injury or death.
 
Manufacturer Narrative
Qn# (b)(4).No part has returned to teleflex chelmsford for investigation.The reported complaint that the "iab catheter ruptured during use on a patient" is not able to be confirmed.If the product is returned at a later date, a full investigation of the sample will be completed.The root cause of the complaint is undetermined.A device history record (dhr) review was conducted for the lot number with no relevant findings.The device passed all manufacturing specifications prior to release.Teleflex assessed the risk for the reported complaint.There are no new or revived risk.This will be monitored for any developing trends.
 
Event Description
It was reported that the intra-aortic balloon (iab) ruptured during use on a patient.As a result, the iab was removed and a second iab was inserted at the same insertion site.There was no report of patient complications, serious injury or death.
 
Manufacturer Narrative
Qn#: (b)(4).Teleflex received the device for investigation.The reported complaint of iab leak suspected is confirmed.During the investigation, a puncture to the bladder, consistent with contact from a sharp object, was found near the proximal end of the bladder membrane which could allow blood to enter the helium pathway.No other leaks were detected during functional testing.The root cause of the bladder leak is undetermined, but a potential cause of how the catheter came into contact with a sharp object is customer handling.A device history record (dhr) review was conducted for the lot number with no relevant findings.The device passed all manufacturing specifications prior to release.Teleflex assessed the risk for the reported complaint.There are no new or revised risk.This will be monitored for any developing trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REDIGUARD IAB: 8FR 40CC
Type of Device
SYSTEM, BALLOON, INTRA-AORTIC
Manufacturer (Section D)
ARROW INTERNATIONAL INC.
reading PA
MDR Report Key10861061
MDR Text Key216878845
Report Number3010532612-2020-00365
Device Sequence Number1
Product Code DSP
UDI-Device Identifier00801902002679
UDI-Public00801902002679
Combination Product (y/n)N
PMA/PMN Number
K981660
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup,Followup
Report Date 11/09/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/31/2020
Device Model NumberIPN000263
Device Catalogue NumberIAB-S840C
Device Lot Number18F19A0026
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/04/2020
Initial Date Manufacturer Received 11/09/2020
Initial Date FDA Received11/18/2020
Supplement Dates Manufacturer Received12/29/2020
05/24/2021
Supplement Dates FDA Received12/30/2020
06/03/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-